national stem-cell therapy logo

REPROCELL USA Secures Funding from Maryland Stem Cell Research Fund (MSCRF)


REPROCELL USA, a leader in the production of clinically relevant human induced pluripotent stem cells (hiPSCs), has announced the receipt of funding from the Maryland Stem Cell Research Fund (MSCRF) for both of its proposals submitted in the January 2024 grant cycle. These grants will significantly enhance the company’s capabilities in cell therapy and therapeutic […]

Accelerating Heart Disease Research: Allen Institute’s New Disease-Specific Cell Lines

stem cells for cardiac health improvement

On June 4, 2024, the Allen Institute for Cell Science announced the launch of its first disease-specific cell line collections, marking a significant milestone in genetic heart disease research. This innovative set of tools, specifically designed to advance the study of hypertrophic cardiomyopathy (HCM) and other muscle disorders, represents a groundbreaking step in the quest […]

REPROCELL USA Launches Advanced GMP Facility for Stem Cell Manufacturing


REPROCELL USA has marked a significant milestone with the inauguration of its state-of-the-art GMP manufacturing facility dedicated to producing high-quality stem cells. This facility, located in Beltsville, Maryland, was officially opened on May 15, 2024, by Mr. Kevin Anderson, Secretary of the Department of Commerce, State of Maryland. The new facility is designed to manufacture […]

Induced Pluripotent Stem Cells (iPSCs): Creation and Applications

detailed illustration of Induced Pluripotent Stem Cells

Welcome, dear readers! Today, we’re embarking on a journey into the microscopic world of cells, specifically stem cells. These aren’t just any ordinary cells; they’re like the superheroes of the cellular world. Imagine a cell that can morph into any cell type in the body, much like a superhero changing disguises. That’s the power of […]

Trailblazing Stem Cell Research: New Hope for Schizophrenia Patients

person suffering from schizophrenia

A recent study led by Dr. Sergiu Pasca at Stanford University suggests that human induced pluripotent stem cells (iPSCs) could be used to identify potential new medications for schizophrenia. The research team developed a novel technique to produce astrocytes, star-shaped cells that support neurons, from iPSCs derived from patients with schizophrenia. Astrocytes play a critical […]